Year |
Citation |
Score |
2018 |
Zangari M, Yoo H, Shin IJ, Yoon D, Suva LJ. Surgical thyroparathyroidectomy prevents progression of 5TGM1 murine multiple myeloma. Journal of Bone Oncology. 12: 19-22. PMID 29556454 DOI: 10.1016/J.Jbo.2018.02.005 |
0.339 |
|
2018 |
Zangari M, Yoo H, Shin I, Kim B, Edmonson R, Morgan GJ, Suva LJ, Yoon D. Thymic PTH Increases after Thyroparathyroidectomy in C57BL6/KaLwRij Mice. Endocrinology. PMID 29381784 DOI: 10.1210/En.2017-03083 |
0.318 |
|
2016 |
Zangari M, Shin I, Branca A, Yoo H, Fallo S, Davies FE, Hoffman B, Fruchtman SM, Yoon D. Rigosertib, a Pan RAS Inhibitor, Decreases Mouse and Human Myeloma Cell Growth in Preclinical Models Blood. 128: 5664-5664. DOI: 10.1182/Blood.V128.22.5664.5664 |
0.34 |
|
2015 |
Divoky V, Song J, Horvathova M, Kralova B, Votavova H, Prchal JT, Yoon D. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor. Journal of Molecular Medicine (Berlin, Germany). PMID 26706855 DOI: 10.1007/S00109-015-1375-Y |
0.377 |
|
2015 |
Song J, Yoon D, Christensen RD, Horvathova M, Thiagarajan P, Prchal JT. HIF-mediated increased ROS from reduced mitophagy and decreased catalase causes neocytolysis. Journal of Molecular Medicine (Berlin, Germany). 93: 857-66. PMID 26017143 DOI: 10.1007/S00109-015-1294-Y |
0.332 |
|
2015 |
Zangari M, Yoo H, Suva L, Yoon D. Thymus-Derived PTH (TPTH) Is Increased after Thyroparathyroidectomy in C57BL6/Kalwrij Mice and Modulates Mouse Sensitivity to 5TGM1 Myeloma Cell Line Blood. 126: 5335-5335. DOI: 10.1182/Blood.V126.23.5335.5335 |
0.345 |
|
2015 |
Song J, Kralova B, Horvathova M, Yoon D, Prchal JT, Divoky V. Polycythemia of Mice with Human Gain-of-Function EPOR (mtHEPOR) Is Transiently Corrected in Perinatal Life in Association with Low Epo and Increased Erythrocyte Phosphatidylserine Exposure Blood. 126: 3335-3335. DOI: 10.1182/Blood.V126.23.3335.3335 |
0.347 |
|
2014 |
Zangari M, Berno T, Yang Y, Zeng M, Xu H, Pappas L, Tricot G, Kamalakar A, Yoon D, Suva LJ. Parathyroid hormone receptor mediates the anti-myeloma effect of proteasome inhibitors. Bone. 61: 39-43. PMID 24389365 DOI: 10.1016/J.Bone.2013.12.025 |
0.339 |
|
2014 |
Zangari M, Stein CK, Yaccoby S, Yoon D, Heuck C, Jethava Y, Johann D, Khan RZ, Papanikolaou X, Rhee Fv, Davies FE, Morgan GJ, Barlogie B. Higher Expressions of PTH Receptor Type 1 and/or 2 in Bone Marrow Is Associated to Longer Survival in Newly Diagnosed Myeloma Patients Enrolled in Total Therapy 3 Blood. 124: 3409-3409. DOI: 10.1182/Blood.V124.21.3409.3409 |
0.353 |
|
2014 |
Zangari M, Yoon D, Yoo H, Kim YS. Surgical Control/Cure of 5TGM1 Murine Multiple Myeloma Model By Thyroparathyroidectomy Blood. 124: 3387-3387. DOI: 10.1182/Blood.V124.21.3387.3387 |
0.33 |
|
2013 |
Tomasic NL, Piterkova L, Huff C, Bilic E, Yoon D, Miasnikova GY, Sergueeva AI, Niu X, Nekhai S, Gordeuk V, Prchal JT. The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W). Haematologica. 98: 560-7. PMID 23403324 DOI: 10.3324/Haematol.2012.070508 |
0.342 |
|
2012 |
Song J, Yoon D, Thiagarajan P, Prchal JT. Molecular Basis of Neocytolysis. Blood. 120: 2093-2093. DOI: 10.1182/Blood.V120.21.2093.2093 |
0.334 |
|
2011 |
Swierczek SI, Yoon D, Bellanné-Chantelot C, Kim SJ, Saint-Martin C, Delhommeau F, Najman A, Prchal JT. Extent of hematopoietic involvement by TET2 mutations in JAK2V⁶¹⁷F polycythemia vera. Haematologica. 96: 775-8. PMID 21273266 DOI: 10.3324/Haematol.2010.029678 |
0.329 |
|
2011 |
Yoon D, Song J, Kim H, Kim B, Shin H, Arnold G, Elliott S, Prchal JT. Tissue-Specific HIF-1 and HIF-2 Regulatory Elements and Their Roles in Erythropoietin Gene Expression Blood. 118: 1303-1303. DOI: 10.1182/Blood.V118.21.1303.1303 |
0.333 |
|
2011 |
Song J, Yoon D, Thiagarajan P, Prchal JT. Neocytolysis Is Associated with Changes in Increase of Mitochondrial Content and Impaired Protection From Reactive Oxygen Species Blood. 118: 1029-1029. DOI: 10.1182/Blood.V118.21.1029.1029 |
0.317 |
|
2010 |
Perrotta S, Cucciolla V, Ferraro M, Ronzoni L, Tramontano A, Rossi F, Scudieri AC, Borriello A, Roberti D, Nobili B, Cappellini MD, Oliva A, Amendola G, Migliaccio AR, Mancuso P, ... ... Yoon D, et al. EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors. Plos One. 5: e12015. PMID 20700488 DOI: 10.1371/Journal.Pone.0012015 |
0.373 |
|
2010 |
Yoon D, Okhotin DV, Kim B, Okhotina Y, Okhotin DJ, Miasnikova GY, Sergueeva AI, Polyakova LA, Maslow A, Lee Y, Semenza GL, Prchal JT, Gordeuk VR. Increased size of solid organs in patients with Chuvash polycythemia and in mice with altered expression of HIF-1alpha and HIF-2alpha. Journal of Molecular Medicine (Berlin, Germany). 88: 523-30. PMID 20140661 DOI: 10.1007/S00109-010-0599-0 |
0.319 |
|
2010 |
Yoon D, Kim SJ, Hickman K, Hussey D, Prchal JT. Study of Two Subjects with Absence of Severe Anemia with Homozygous β0 Thalassemia Due to Disrupted γ-to-β Switch Blood. 116: 5172-5172. DOI: 10.1182/Blood.V116.21.5172.5172 |
0.332 |
|
2010 |
Swierczek S, Yoon D, Hickman K, Prchal JT. MicroRNA-101 Is Down-Regulated In PV and ET Granulocytes and Its Decrease Is Associated with Over-Expression of Histone Methyltransferase In EZH2 In MPN Patients Blood. 116: 1989-1989. DOI: 10.1182/Blood.V116.21.1989.1989 |
0.314 |
|
2009 |
Hegde S, Ni S, He S, Yoon D, Feng GS, Watowich SS, Paulson RF, Hankey PA. Stat3 promotes the development of erythroleukemia by inducing Pu.1 expression and inhibiting erythroid differentiation. Oncogene. 28: 3349-59. PMID 19581930 DOI: 10.1038/Onc.2009.202 |
0.57 |
|
2009 |
Bruchova H, Yoon D, Agarwal AM, Swierczek S, Prchal JT. Erythropoiesis in polycythemia vera is hyper-proliferative and has accelerated maturation. Blood Cells, Molecules & Diseases. 43: 81-7. PMID 19264517 DOI: 10.1016/J.Bcmd.2009.02.001 |
0.381 |
|
2009 |
Yoon D, Okhotin D, Kim B, Okhotina Y, Okhotin DJ, Miasnikova GY, Sergueeva AI, Polyakova LA, Maslow A, Lee Y, Semenza GL, Prchal JT, Gordeuk VR. Increased Ratios of Internal Organ Volume to Body Mass in Chuvash Polycythemia and HIF-2α Repression of p21Cip Expression through C-MYC. Blood. 114: 5039-5039. DOI: 10.1182/Blood.V114.22.5039.5039 |
0.348 |
|
2009 |
Swierczek S, Bellanne-Chantelot C, Yoon D, Saint-Martin C, Kim SJ, Najman A, Prchal JT. TET2 Mutations in Polycythemia Vera (PV) in Some Cases Follow Rather Than Precede JAK2 V617F Mutation, Are Not a Disease-Initiating Event, Affect Mainly Erythropoiesis, and Contribute to Increased Aggressivity of PV Clone. Blood. 114: 3913-3913. DOI: 10.1182/Blood.V114.22.3913.3913 |
0.356 |
|
2008 |
Yoon D, Kim B, Prchal JT. Cre recombinase expression controlled by the hematopoietic regulatory domain of Gata-1 is erythroid-specific. Blood Cells, Molecules & Diseases. 40: 381-7. PMID 18077194 DOI: 10.1016/J.Bcmd.2007.10.008 |
0.367 |
|
2007 |
Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT. Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Experimental Hematology. 35: 1657-67. PMID 17976518 DOI: 10.1016/J.Exphem.2007.08.021 |
0.321 |
|
2007 |
Swierczek SI, Yoon D, Prchal JT. Blast Transformation in a Patient with Primary Myelofibrosis Initiated from JAK2 V617F Progenitor. Blood. 110: 4665-4665. DOI: 10.1182/Blood.V110.11.4665.4665 |
0.367 |
|
2007 |
Yoon D, Prchal J. Truncated Human Erythropoietin Receptor Causes Fetal Polycythemia and Is Associated with a Prolonged Primitive Erythropoiesis and Hyperactive Definitive Erythropoiesis. Blood. 110: 3664-3664. DOI: 10.1182/Blood.V110.11.3664.3664 |
0.346 |
|
2007 |
Bruchova H, Yoon D, Agarwal A, Otahalova E, Kim H, Prchal JT. Erythropoiesis in Polycythemia Vera Is Hyper-Proliferative and Has Accelerated Differentiation during In Vitro Erythroid Expansion and Is Associated with Higher Expressions of cMYB and EPOR at Early Erythroid Progenitors Blood. 110: 1549-1549. DOI: 10.1182/Blood.V110.11.1549.1549 |
0.333 |
|
2006 |
Yoon D, Pastore YD, Divoky V, Liu E, Mlodnicka AE, Rainey K, Ponka P, Semenza GL, Schumacher A, Prchal JT. Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. The Journal of Biological Chemistry. 281: 25703-11. PMID 16787915 DOI: 10.1074/Jbc.M602329200 |
0.334 |
|
2006 |
Yoon D, Bruchova H, Agarwal AM, Prchal JT, Prchal JF. In Vitro Erythroid Cell Expansion Analysis in Polycythemia Vera. Blood. 108: 4916-4916. DOI: 10.1182/Blood.V108.11.4916.4916 |
0.352 |
|
2006 |
Yoon D, Kim B, Kwon M, Prchal JT. Hematopoietic Specific GATA-1-Improved Cre Mouse for Erythroid-Specific Gene Modification. Blood. 108: 1291-1291. DOI: 10.1182/Blood.V108.11.1291.1291 |
0.374 |
|
2005 |
Yoon D, Watowich SS, Prchal JT. Truncated Human EpoR Causes Polycythemia in Fetal Erythropoiesis through Stat5 Hyperactivation. Blood. 106: 567-567. DOI: 10.1182/Blood.V106.11.567.567 |
0.603 |
|
2005 |
Gaikwad AS, Verstovsek S, Chang K, Yoon D, Vainchenker W, Cortes J, Prchal JT. Will Imitanib Be Useful for Patients with Polycythemia Vera Blood. 106: 2601-2601. DOI: 10.1182/Blood.V106.11.2601.2601 |
0.404 |
|
2004 |
Panopoulos AD, Yoon D, Zhang L, Watowich SS. Stat3 Is Required for In Vivo G-CSF-Responsiveness and Neutrophil Function. Blood. 104: 817-817. DOI: 10.1182/Blood.V104.11.817.817 |
0.581 |
|
2003 |
Yoon D, Watowich SS. Hematopoietic cell survival signals are elicited through non-tyrosine-containing sequences in the membrane-proximal region of the erythropoietin receptor (EPOR) by a Stat5-dependent pathway. Experimental Hematology. 31: 1310-6. PMID 14662339 DOI: 10.1016/J.Exphem.2003.08.009 |
0.572 |
|
Show low-probability matches. |